Walleye Trading
HZNP

Walleye Trading’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Walleye Trading’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,305,400
Closed -$382M – 5729
2023
Q3 		$382M Buy
3,305,400
+1,851,500
+127% +$199M 1% 9
2023
Q2 		$150M Buy
1,453,900
+1,168,000
+409% +$123M 0.45% 26
2023
Q1 		$31.2M Buy
285,900
+139,200
+95% +$15.4M 0.07% 245
2022
Q4 		$16.7M Buy
146,700
+143,800
+4,959% +$11.9M 0.05% 437
2022
Q3 		$179K Buy
2,900
+600
+26% +$41.9K ﹤0.01% 3762
2022
Q2 		$183K Sell
2,300
-102,100
-98% -$9.67M ﹤0.01% 3751
2022
Q1 		$11M Buy
104,400
+97,200
+1,350% +$9.47M 0.04% 593
2021
Q4 		$776K Buy
7,200
+3,900
+118% +$425K ﹤0.01% 2488
2021
Q3 		$361K Sell
3,300
-15,400
-82% -$1.6M ﹤0.01% 3271
2021
Q2 		$1.75M Buy
18,700
+8,200
+78% +$755K 0.01% 1607
2021
Q1 		$966K Buy
10,500
+5,200
+98% +$439K ﹤0.01% 1948
2020
Q4 		$388K Sell
5,300
-27,700
-84% -$2.06M ﹤0.01% 2908
2020
Q3 		$2.56M Sell
33,000
-15,700
-32% -$1.08M 0.01% 960
2020
Q2 		$2.71M Buy
48,700
+33,100
+212% +$1.42M 0.02% 884
2020
Q1 		$462K Sell
15,600
-17,100
-52% -$579K ﹤0.01% 1937
2019
Q4 		$1.18M Sell
32,700
-1,300
-4% -$39.9K 0.01% 1649
2019
Q3 		$926K Buy
34,000
+2,900
+9% +$75K 0.01% 1657
2019
Q2 		$748K Sell
31,100
-10,900
-26% -$276K 0.01% 1846
2019
Q1 		$1.11M Sell
42,000
-39,300
-48% -$931K 0.01% 1557
2018
Q4 		$1.59M Sell
81,300
-86,500
-52% -$1.7M 0.01% 1257
2018
Q3 		$3.29M Sell
167,800
-6,400
-4% -$122K 0.02% 922
2018
Q2 		$2.88M Buy
174,200
+136,900
+367% +$2.09M 0.02% 998
2018
Q1 		$530K Buy
37,300
+20,500
+122% +$303K ﹤0.01% 2609
2017
Q4 		$243K Sell
16,800
-139,200
-89% -$1.96M ﹤0.01% 3301
2017
Q3 		$1.98M Buy
156,000
+139,000
+818% +$1.77M 0.01% 1272
2017
Q2 		$201K Sell
17,000
-16,500
-49% -$205K ﹤0.01% 3111
2017
Q1 		$493K Sell
33,500
-21,300
-39% -$345K ﹤0.01% 2243
2016
Q4 		$887K Buy
54,800
+24,300
+80% +$441K 0.01% 1606
2016
Q3 		$554K Buy
30,500
+8,500
+39% +$166K ﹤0.01% 2053
2016
Q2 		$363K Sell
22,000
-3,300
-13% -$53.4K ﹤0.01% 2491
2016
Q1 		$419K Buy
25,300
+1,800
+8% +$31.5K ﹤0.01% 2119
2015
Q4 		$511K Buy
23,500
+14,500
+161% +$282K 0.01% 1831
2015
Q3 		$179K Buy
9,000
+6,700
+291% +$212K ﹤0.01% 2449
2015
Q2 		$80K Buy
+2,300
New +$70.2K ﹤0.01% 3195

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Walleye Trading's HZNP Position: Q3 2022 in Review

Walleye Trading sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2022, closing a stake of 502 shares — an estimated $35.1K sold.

Walleye Trading first reported a position in HZNP in Q2 2015 and held it in 18 quarters. The position peaked at $5.87M in Q1 2021. 529 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.

  • Walleye Trading reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2022 after selling out during the quarter.
  • Walleye Trading sold 502 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $35.1K.
  • Walleye Trading first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2015 and held it in 18 quarters.
  • Walleye Trading's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $5.87M in Q1 2021.
  • 529 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.

Based on Walleye Trading's 13F filing for Q3 2022, filed 14 Nov 2022.